Softwr

Healthcare · head to head

Therapixel vs VideaHealth

Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
VideaHealth logo

VideaHealth

Dental

FDA-cleared AI for dental X-ray analysis

From
$399/month
Rated
-

The short version

  • Each has a real cost: Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.; VideaHealth not a standalone practice management system; requires integration with existing practice software
  • They diverge on capability: Therapixel covers MammoScreen 2D, VideaHealth covers FDA-cleared AI detection.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Therapixel and VideaHealth actually diverge.

Attributes where Therapixel and VideaHealth differ
AttributeTherapixelVideaHealth
Starting priceOn request$399/month
Pricing modelquotesubscription
CategoryHealthcareDental
FoundedUnknown2022

Identical on both: free tier (No), platforms (Web), user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

Only in VideaHealth

  • FDA-cleared AI detection
  • Cavity detection
  • Bone loss analysis
  • Real-time results
  • Patient education tools
  • Dexis
  • Patterson Imaging
  • Carestream

What people use each for

The jobs each tool is most often brought in to do.

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot VideaHealth
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot VideaHealth
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot VideaHealth
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot VideaHealth

VideaHealth

  • Diagnostic assistancenot Therapixel
  • Treatment planningnot Therapixel
  • Patient communicationnot Therapixel

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

VideaHealth

  • Not a standalone practice management system; requires integration with existing practice software
  • Focuses only on imaging analysis; does not handle billing, scheduling, or patient records directly
  • Pricing not publicly disclosed

Pricing, plan by plan

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

VideaHealth

$399/month
  • Practice$399/month
    • AI X-ray analysis
    • Real-time detection
    • Treatment insights
  • Enterprise$799/month
    • Multi-location
    • Advanced analytics
    • API access

Which should you pick?

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.

Choose VideaHealth if

  • You need fda-cleared ai detection.
  • You also want cavity detection.

Questions people ask

Is Therapixel or VideaHealth better?
Neither clearly leads. Therapixel starts at On request and VideaHealth at $399/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Therapixel or VideaHealth?
Therapixel starts at On request and VideaHealth at $399/month.
Does Therapixel or VideaHealth run on more platforms?
Both run on Web, so platform support will not decide this one for you.
What is Therapixel best used for?
Therapixel is most often used for a european breast screening programme running mandatory double reading that wants to evaluate ai as a concurrent or second reader within what national guidance permits, an american breast centre that has moved to tomosynthesis and needs reading support on dbt specifically, which therapixel holds a clearance for, a screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own threshold, a radiology group evaluating multiple mammography ai vendors head to head on their own historic case set before committing. Of those, a european breast screening programme running mandatory double reading that wants to evaluate ai as a concurrent or second reader within what national guidance permits and an american breast centre that has moved to tomosynthesis and needs reading support on dbt specifically, which therapixel holds a clearance for are not what VideaHealth is typically brought in for.
What can Therapixel do that VideaHealth cannot?
Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report. VideaHealth covers FDA-cleared AI detection, Cavity detection, Bone loss analysis, Real-time results.

Answered from the vendors’ own pages

Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

VideaHealth: What does VideaHealth detect in dental images?

VideaHealth's AI detects over 30 dental conditions on 2D radiographs to assist clinicians in diagnosis and treatment planning.

Source
Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

VideaHealth: Is VideaHealth a standalone practice management system?

No. VideaHealth is an AI imaging platform that integrates with existing dental practice management systems, not a complete practice management solution.

Source
Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

VideaHealth: Which practice management systems does VideaHealth work with?

VideaHealth integrates with Henry Schein One's Dentrix and Dentrix Ascend platforms. It is designed to work with approximately 90% of dental imaging systems.

Source
Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

VideaHealth: Who uses VideaHealth?

VideaHealth is used by major dental service organizations (DSOs) including Heartland Dental, 42 North Dental, and DentalCorp, as well as private dental practices.

Source
Share

Related pages

Other head to heads